Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Cognito Therapeutics develops Spectris, a non-invasive sensory stimulation technology platform to treat neurodegenerative diseases including Alzheimer's by improving cognitive performance. The company serves patients with neurodegenerative conditions and aims to transform disease management through clinical-to-commercial pathways in the neurological therapeutics sector.
2 investors
Cohesys is a medical device company developing BoneTape, a resorbable material solution for fracture repair designed to replace traditional invasive surgical plates and screws in orthopedic treatment.
2 investors
Coloursmith develops precision light-filtering ingredients for contact lenses using patented chromophore encapsulation technology, enabling lens manufacturers to create products with improved light protection and comfort.
2 investors
Colospan develops CG-100, a CE-marked intraluminal bypass device made of soft silicone that is placed through the anus to protect the surgical site after colorectal surgery, serving as an alternative to a diverting stoma. The device targets colorectal surgery patients at risk of anastomotic leaks, aiming to avoid a second reversal procedure and reduce complications for patients, physicians, and payers.
2 investors
COMBAT Medical develops patented hyperthermic medical devices used to treat bladder and peritoneal cancers, deployed in hospitals across more than 40 countries. The company conducts clinical trials and evidence-based studies and works with healthcare professionals and a global distributor network to make its systems available to cancer patients.
2 investors
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.
2 investors
Concha Labs makes Concha Sol, an FDA-cleared over-the-counter self-fitting hearing aid that uses patented technology to personalize a user's sound profile, with a focus on hearing speech in noisy environments. The devices are aimed at individuals with mild-to-moderate hearing loss and are set up at home.
2 investors
CoNextions Medical develops implantable devices for orthopaedic soft tissue repair, including systems for tendon repair and soft tissue-to-bone fixation intended for use by surgeons. Its implants are designed to replace or improve on conventional suture-based repair methods.
2 investors
Coologics develops a drug-free medical device designed to treat vaginal yeast and bacterial infections through controlled cooling technology. The device targets women seeking non-pharmaceutical relief and clinical cure from recurrent infections.
2 investors
CoolSculpting offers FDA-cleared body-contouring procedures that use controlled cooling to reduce visible fat bulges in areas such as the chin, abdomen, thighs, and flanks, along with the CoolTone device for muscle strengthening and toning. The procedures are administered under medical supervision and are marketed to consumers seeking non-surgical fat reduction and muscle stimulation rather than weight loss.
2 investors
CoolStat is an investigational medical device that delivers dry air through the nasal passages to cool patients with fever and other conditions, currently being studied in clinical trials for neurogenic fever, cardiac arrest, and migraine pain management.
2 investors
CoraVie Medical is an early-stage company developing an implantable, ultrasound-based device for continuous, long-term blood pressure monitoring in people with hypertension. The system provides automatic measurement without cuffs or manual logging, aimed at giving physicians more reliable data for earlier intervention.
2 investors
Corcept develops cortisol modulators β molecules that regulate cortisol activity at the glucocorticoid receptor β to treat serious diseases across endocrinology, oncology, metabolism, and neurology. Its FDA-approved drug Korlym (mifepristone) treats hypercortisolism (Cushing syndrome), and the company has over 30 ongoing studies and more than 1,000 discovered proprietary cortisol modulators.
2 investors
Corcym is a global medical device company focused on structural heart disease, developing heart valve prostheses and repair devices such as sutureless aortic heart valves. It serves healthcare professionals and cardiac patients, and offers professional education programs in partnership with scientific societies.
2 investors
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care. Its products are used by healthcare professionals and patients.
2 investors
CORE Biomedicine is a biotech company developing precision cancer medicines based on cancer lineage biology, focused on advancing drug candidates from discovery into clinical development.
2 investors
CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
2 investors
Corvion develops a fully implanted left ventricular assist device (LVAD) for patients with severe heart failure, featuring a high-efficiency magnetically levitated pump, a small implantable battery/controller, and wireless charging. The system eliminates the external driveline and cables used by competing mechanical circulatory support devices to reduce infection and stroke risk.
2 investors
CorWave is a medical device company developing heart-assist pumps designed as a physiological solution for patients with heart failure. It focuses on deep tech innovation in the cardiac care and implantable medical device space.
2 investors
Cosm provides software and 3D printing technology that let clinicians create personalized pessaries fitted to each patient's needs, addressing pelvic organ prolapse and incontinence. Its products are Health Canada licensed and FDA cleared, serving pelvic health providers and their female patients.
2 investors
Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.
2 investors
Cotton Mouton Diagnostics operates a UKAS-accredited laboratory offering endotoxin testing services for liquid pharmaceutical products, including method development, validation, and low endotoxin recovery studies. It also produces the Ξ±BET System, an in-house testing platform combining FUJIFILM Wako's licensed LAL reagent with its own magneto-optical technology for pharmaceutical and diagnostics customers.
2 investors
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
2 investors
CranioSense develops IPASS, a non-invasive medical device that measures intracranial pressure using a forehead patch and handheld device, eliminating the need for invasive skull drilling in traumatic brain injury assessment.
2 investors